Emily Bodnar’s score relies over the anticipation of significant milestones for Agenus in the coming yr, especially the opportunity filing of the Biologics License Software (BLA) for his or her guide drug prospect, botensilimab (bot). Agenus has dosed over 900 people with bot throughout numerous strong tumors, showing a determination to in depth